Breaking News: Clinical Trial Results in Pulmonary Medicine

An ATS 2020 Virtual session of late-breaking information on leading clinical trials affecting the pulmonary, critical care, and sleep community.

Program Lineup

Welcome and Introduction by the Chair
MeiLan K. Han, MD, MS, Ann Arbor, MI

Inhaled Triple Therapy at Two Glucocorticoid Doses in Moderate-to-Very Severe COPD: The ETHOS Study
Klaus F. Rabe, MD, PhD, Grossensdorf, Germany

Questions/Answers
Facilitator: MeiLan K. Han, MD, MS, Ann Arbor, MI

Phase 2 Randomized Controlled Trial of DPP1 Inhibitor Brensocatib (INS1007) in Patients with Bronchiectasis: the WILLOW Study
James D. Chalmers, MD, ChB, PhD, Dundee, United Kingdom

Questions/Answers
Facilitator: Jennifer L. Taylor-Cousar, MD, MSc, ATSF, Denver, CO

Inhaled Treprostinil in Interstitial Lung Disease Associated Pulmonary Hypertension: The INCREASE Study
Steven D. Nathan, MD, Falls Church, VA

Questions/Answers
Facilitator: Martin R.J. Kolb, PhD, MD, Hamilton, Canada

Sotatercept for the Treatment of Pulmonary Arterial Hypertension
David B. Badesch, MD, Aurora, CO

Questions/Answers
Facilitator: Steven M. Kawut, MD, MS, ATSF, Philadelphia, PA

Thank you and Adjournment
MeiLan K. Han, MD, MS, Ann Arbor, MI

source